Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis.
Johnson WT, Epstein-Peterson ZD, Ganesan N, Pak T, Chang T, Dao P, Moskowitz AJ, Stuver RN, Ghione P, Galasso N, Khan N, Palomba ML, Caron PC, Kumar A, Tamari R, Lue JK, Noy A, Falchi L, Intlekofer AM, Gyurkocza B, Perales MA, Scordo M, Herskovits AZ, Salles G, Vardhana SA, Horwitz SM. Johnson WT, et al. Among authors: chang t. Haematologica. 2024 Sep 1;109(9):2998-3003. doi: 10.3324/haematol.2023.284179. Haematologica. 2024. PMID: 38752279 Free PMC article. No abstract available.
The real-time fMRI neurofeedback based stratification of Default Network Regulation Neuroimaging data repository.
McDonald AR, Muraskin J, Dam NTV, Froehlich C, Puccio B, Pellman J, Bauer CCC, Akeyson A, Breland MM, Calhoun VD, Carter S, Chang TP, Gessner C, Gianonne A, Giavasis S, Glass J, Homann S, King M, Kramer M, Landis D, Lieval A, Lisinski J, Mackay-Brandt A, Miller B, Panek L, Reed H, Santiago C, Schoell E, Sinnig R, Sital M, Taverna E, Tobe R, Trautman K, Varghese B, Walden L, Wang R, Waters AB, Wood DC, Castellanos FX, Leventhal B, Colcombe SJ, LaConte S, Milham MP, Craddock RC. McDonald AR, et al. Among authors: chang tp. Neuroimage. 2017 Feb 1;146:157-170. doi: 10.1016/j.neuroimage.2016.10.048. Epub 2016 Nov 9. Neuroimage. 2017. PMID: 27836708 Free PMC article.
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settings.
Chiang CM, Huang KK, Lee CT, Hong TC, Wu JS, Wu HT, Chang TT, Liu YS, Chen WT, Wang CT, Chang C, Chen PJ, Hsieh MT, Chen CY, Chuang CH, Lee CC, Lin SH, Lin YJ, Kuo HY. Chiang CM, et al. Among authors: chang tt. Ther Adv Med Oncol. 2025 Jan 7;17:17588359241312141. doi: 10.1177/17588359241312141. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 39801612 Free PMC article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
9,155 results